Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer

Clinical trial NCT05450484 · COMPLETED

Trial details

NCT number: NCT05450484
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2023-04-05
Primary completion: 2024-11-25
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.